PS

Parmendra Singh

Active Director Director DIN 07592942
DIN 07592942 First appointment Nov 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Parmendra Singh

Data last updated:

Parmendra Singh is a Director at Medichiron Pharmaceuticals Private Limited (since 2016). The company operates in Business Services.

DIN 07592942
Primary Designation Director
Industry Business Services
First Appointment 07 Nov 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Nov 20162016Active

Board colleagues of Parmendra Singh

NameDINCompanyDesignation
Autar Singh07592936Medichiron Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medichiron Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Parmendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parmendra Singh

Parmendra Singh currently holds 1 directorship: Medichiron Pharmaceuticals Private Limited (Director, since 07 Nov 2016).

Parmendra Singh was first appointed on 07 Nov 2016 as Director at Medichiron Pharmaceuticals Private Limited.

The current boards of Parmendra Singh's companies include Autar Singh (Medichiron Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available